Aureomycin Therapy in the Pulmonary Involvement of Pancreatic Fibrosis (Mucoviscidosis)

Abstract

THIS report is concerned with aureomycin∥ in the treatment of patients with pancreatic fibrosis (cystic fibrosis of the pancreas).^{1 2 3} Numerous advances in the understanding of the nature of the disease, development of diagnostic procedures and clinical management have been made in a series of correlated studies carried out at the Boston Children's Hospital.^{4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21} The common notion that this is a rare disease and that the immediate prognosis is always poor is no longer tenable. Another misconception, perhaps based on historical and nosologic grounds, is the view that this is a disease solely of the pancreas and that involvement of other . . .